drugset / Trial / NCT06705777

Randomized Study of Oral Aesculus Hippocastanum and Combinations in Hemorrhoidal Disease After 60 Days of Treatment

NCT06705777

NaSingle-groupOpen-labelTreatment

Summary

To demonstrate the clinical efficacy of the combination of Aesculus hippocastanum, Polygonum acre, Smilax Pepyracea, and rutin in tablets in improving local symptoms (bleeding, pain, thrombosis, perianal dermatitis, hemorrhoidal nipple prolapse) assessed using a 100mm visual scale (VAS) over 60 days among adult patients with grade 1, 2 or 3 hemorrhoidal disease.

Timeline

Start
2024-09-01
Primary completion
2025-09-01
Completion
2025-11-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Horse Chestnut Unknown 10 mg
Subject Polygonum acre Unknown 10 mg
Subject Rutin Unknown 20 mg
Subject Smilax Papyracea Unknown 40 mg

Indications